Expanding waistline linked to an increased risk of cancer
Conclusion
This study provides more evidence of the link between excess body fat and 10 cancers. Though the percentage increases sound large, it's important to put these results into context.
For example, the baseline risk of postmenopausal cancer was 2.2% – it occurred in 555 of the 24,751 women in the study.
For women who hadn't used hormone therapy, this would increase to a risk of 2.7% if they had a BMI of 30 compared with 26, or a waist circumference of 95cm compared with 84cm. This accounts for only an extra 5 cases in every 1,000 women.
This large study involved older adults from European countries, so the resu...
Source: NHS News Feed - May 25, 2017 Category: Consumer Health News Tags: Cancer Obesity Source Type: news
Adjuvant Oral Chemo in Biliary Tract Cancer Extended Survival
The addition of adjuvant oral chemotherapy with capecitabine extended the overall survival of patients with biliary cancers by a median of 15 months, according to the results of the BILCAP study. (Source: CancerNetwork)
Source: CancerNetwork - May 18, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO Gastrointestinal Cancer Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news
Oral chemotherapy extends survival by more than a year in biliary tract cancer
(American Society of Clinical Oncology) A phase III randomized clinical trial of 447 patients with biliary tract cancers (BTCs, cancers of the bile duct and gallbladder) showed that giving capecitabine after surgery extends survival by a median of 15 months compared to surgery alone. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 17, 2017 Category: Cancer & Oncology Source Type: news
FDA Approves Regorafenib for Liver Cancer
The FDA has approved regorafenib (Stivarga) for the second-line treatment of hepatocellular carcinoma (HCC) for patients who have previously received sorafenib. (Source: CancerNetwork)
Source: CancerNetwork - April 28, 2017 Category: Cancer & Oncology Authors: Ian Ingram Tags: Gastrointestinal Cancer Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news
Gallbladder cancer rates decreasing in men, not women; late-stage diagnosis on the rise
(University of Missouri-Columbia) Gallbladder cancer is a rare, but aggressive disease. A new study by University of Missouri School of Medicine researchers has found that gallbladder cancer rates have decreased in men in recent years but not in women. The researchers also found that more people are being diagnosed with late-stage disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 24, 2017 Category: Cancer & Oncology Source Type: news
Nivolumab Yields 12-Month Survival of Nearly 60% in Advanced HCC
Interim data from CheckMate 040 showed that nivolumab produces durable responses with promising long-term survival rates in patients with advanced, unresectable hepatocellular carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - April 21, 2017 Category: Cancer & Oncology Authors: Ian Ingram Tags: Gastrointestinal Cancer Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news
Young Obese Men at Risk for Liver Cancer
Young men who are overweight or obese are at risk of developing severe liver disease or liver cancer in later life, particularly those who have type 2 diabetes mellitus. (Source: CancerNetwork)
Source: CancerNetwork - March 29, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Gastrointestinal Cancer Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news
Overweight young men 'more likely to get severe liver disease'
Conclusion
This cohort study aimed to assess whether a high BMI in late adolescence is associated with an increased risk of severe liver disease and liver cancer in later life.
The researchers generally found a higher BMI was associated with an increased risk of severe liver disease, including liver cancer.
A diagnosis of type 2 diabetes during follow-up was associated with a further increased risk of severe liver disease, regardless of BMI at the start of the study.
This study included a very large population, and has used reliable sources of data for medical diagnoses and cause of death.
But there are limitations to ...
Source: NHS News Feed - March 21, 2017 Category: Consumer Health News Tags: Obesity Cancer Source Type: news
Study identifies common gene variants associated with gallbladder cancer
(Johns Hopkins University Bloomberg School of Public Health) By comparing the genetic code of gallbladder cancer patients with those of healthy volunteers at nearly 700,000 different locations in the genome, researchers say they have found several gene variants which may predispose individuals to develop the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 5, 2017 Category: Global & Universal Source Type: news
Wide range of cancers now linked to being overweight
Conclusion
The results of this study provide further evidence for the link between increasing levels of fat and the risk of developing certain cancers.
There was strong evidence for nine cancers, with another two – ovarian cancer and stomach cancer – included when comparing obesity with healthy weight.
This study is important in showing the significance of fat levels and obesity in cancer risk.
But there are some important things to consider:
The study doesn't tell us how excess body fat might play a role in the development of certain cancers, just that there's a link.
Some studies might have been missed, as th...
Source: NHS News Feed - March 1, 2017 Category: Consumer Health News Tags: Cancer Obesity Source Type: news
Adjuvant GEMOX Did Not Improve RFS for Localized Biliary Tract Cancer
Adjuvant chemotherapy for biliary tract cancer using GEMOX (gemcitabine/oxaliplatin) was feasible, but did not result in an improved recurrence-free survival or quality of life compared with surveillance in the phase III PRODIGE 12-ACCORD 18 trial. (Source: CancerNetwork)
Source: CancerNetwork - January 23, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO 2017 Gastrointestinal Cancers Symposium Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news
Cancer Facts and Figures: Death Rate Down 25% Since 1991
By Stacy Simon The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society. The cancer death rate for men and women combined fell 25% from its peak in 1991 to 2014, the most recent year for which data are available. This decline translates to more than 2.1 million deaths averted during this time period. “Cancer Statistics, 2017,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the US this year. The estimat...
Source: American Cancer Society :: News and Features - January 5, 2017 Category: Cancer & Oncology Tags: General Information Source Type: news
10 Powerful Survivor Stories From 2016
In Stories of Hope, we regularly publish the stories of people who have a positive message to share, whether their cancer diagnosis was just recently, or long ago. Our featured survivors share words of inspiration, wisdom, hope, and support in these stories about how their lives have been changed by cancer. Our editors have chosen 10 of the most inspirational stories of 2016. For many who are facing a cancer diagnosis, or any other illness or hardship, hearing from others who've been through one already can be a great source of comfort and support. We hope you will find inspiration in these stories of cancer survivors. &nb...
Source: American Cancer Society :: News and Features - December 21, 2016 Category: Cancer & Oncology Tags: Coping with Cancer Source Type: news
Tumors Make Their Won Blood Vessels
By Drs. David Niesel and Norbert Herzog
It is well established that tumors can induce our own cells to form new blood in a process called angiogenesis. This supplies tumors with the nutrients and oxygen to support their growth. But in 1999, scientists hypothesized that tumor cells themselves can form blood vessels, a process called vasculogenic mimicry or VM. That started a fierce, but healthy debate about how tumors acquire their blood supply. Nearly 17 years later, a drug that targets VM has gone into clinical trials and if successful would go a long way in bolstering the case that this phenomenon contributes to tumor g...
Source: Science - The Huffington Post - December 19, 2016 Category: Science Source Type: news
Better late than never as they say! – Karron ’ s story
I write this story some 6 months after my hysterectomy, I was one of those people that used to pop in and read all the stories, which I must confess really helped me, especially the hints and the special things that would help. So here is my story. Sorry it is late.
I presented at A&E this time last year with gallstone pancreatitis seriously ill, at the time the medics found I had a mass in my womb, which I did not know about, I just thought I had a bulky tummy. Turns out my womb was full of fibroids, totally obstructing the whole of the womb. This made sense retrospectively as I was starting to have problems with my b...
Source: The Hysterectomy Association - December 8, 2016 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health fibroids hysterectomy stories Source Type: news
